Hypertrophic cardiomyopathy is an uncommon disorder of cardiac muscle typically on a genetic basis; however, the relationship of specific genotypes to clinical presentation is complex and still poorly characterized. Hypertrophic cardiomyopathy can be associated with outflow track obstruction, heart failure, and arrhythmias – it thus presents an important diagnostic and therapeutic challenge to the managing physicians. The physiology is complex, but has major implications for the patient’s lifestyle, ability to tolerate surgery, and life expectancy.

Course Details

In this course, you will learn:
  • To describe the hemodynamic abnormalities that can occur with the various forms of hypertrophic cardiomyopathy.
  • To enumerate medications that are specifically indicated, and those that are specifically contra-indicated, in the various forms of hypertrophic cardiomyopathy.
  • To define patient subsets who that might be appropriate for alcohol septal ablation, surgical myomectomy, or placement of an automatic implantable cardioverter defibrillator (AICD).

Method and medium:

Learners participate in the interactive learning modules by correctly answering multiple choice questions dispersed throughout. Learners will be prompted to try again if a question is answered incorrectly.

The course will open in a new tab – to exit the course, simply close that tab.


Estimated time to Complete: 20 minutes
Credit/contact hours: .25 hours
Expiration date: March 7, 2021
Publication date: March 8, 2018

User Rating: 5/5 (2) Rating Details

Course Author

Michael Ragosta III, MD

Professor of Medicine/Cardiology

Dr. Michael Ragosta is an attending cardiologist at the University of Virginia Health System with a sub-specialty in interventional cardiology. 
Learn More about Michael Ragosta III, MD.

DISCLOSURE: This individual reports no relevant financial relationships with commercial entities.